PRESS RELEASE
Published August 9, 2023
The Global Allergy Immunotherapy Market is poised to register a CAGR of 8.8% during the forecast period 2023 to 2031.
Table of Contents
Allergy Immunotherapy Market Introduction
Allergy immunotherapy, also known as allergy shots, is a medical treatment used to reduce or eliminate the symptoms of allergic reactions. It is a form of immunotherapy that involves exposing a patient to small doses of an allergen, such as pollen or pet dander, over a period of time. The goal of allergy immunotherapy is to help the patient's immune system build up a tolerance to the allergen. This is achieved by gradually increasing the dosage of the allergen over time, which helps the immune system recognize the allergen as harmless and stop producing an allergic response. Allergy immunotherapy is typically used to treat allergic rhinitis (hay fever), allergic asthma, and insect sting allergies. It is often advised for individuals who don't react to or are unable to handle conventional allergy treatments, such antihistamines or nasal corticosteroids.
FutureWise Market Research has published a report that provides an insightful analysis of Allergy Immunotherapy Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry.
By the end of the forecast period FutureWise research analysts project that Allergy Immunotherapy Market will experience significant growth. According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, and further assist in making better strategic and expansion decisions by key stakeholders of an organization.
Allergy Immunotherapy Market Segmentation:
By Treatment Type
• Subcutaneous Immunotherapy
• Sublingual Immunotherapy
o Tablets
o Drops
By Allergy Type
• Allergic Rhinitis
• Allergic Asthma
• Others
By End User
• Hospital
• Retail Pharmacy
• Online Pharmacy
By Region
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa
This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.
Get a Sample of the Allergy Immunotherapy Market Report @
www.futurewiseresearch.com/healthcare-market-research/Allergy-Immunotherapy-Market/4150
Major players included in the Allergy Immunotherapy Market:
• ASIT Biotech
• Circassia
• Mylan N.V
• Adamis Pharmaceuticals Corporation
• Merck KGaA
• Stallergenes Greer plc
• Allergy Therapeutics
• Hollisterstier Allergy
• Letip harma
• DBV Technologies SA
Recent developments by key players in Allergy Immunotherapy Market:
In March 2022, PVX108, a cutting-edge immunotherapy for the treatment of peanut allergy, has begun Phase 2 clinical trials, according to an announcement from Aravax Pty Ltd.
Drivers of Allergy Immunotherapy Market
Increasing incidence of allergic disorders.
A significant aspect boosting market revenue growth is the rising prevalence of allergy diseases. Allergen immunotherapy significantly minimises the requirement for further medication while also improving allergy symptoms. In young individuals with allergic rhinitis, immunotherapy delays the onset of asthma. Almost 30% of people worldwide, according to the American Academy of Allergy Asthma & Immunology, suffer from allergic rhinitis. Moreover, the market for allergy immunotherapy is seeing revenue growth due to the increased frequency of various allergic disorders including medication allergies, food allergies, and respiratory allergies like allergic asthma.
Restraint of Allergy Immunotherapy Market
Risk Factors associated with allergy immunotherapy
Allergy Immunotherapy has certain drawbacks, including systemic allergic responses, occasional anaphylaxis, and even mortality. Subcutaneous injection is a significant concern that might restrain market revenue development. Moreover, extremely high sensitivity, being exposed to seasonal allergens, and having bronchial asthma are risk factors for systemic responses. Anaphylaxis is an uncommon but possibly lethal response to allergy injections. It causes low blood pressure and breathing problems, which might limit market revenue development.
Opportunity of Allergy Immunotherapy Market
Growing Awareness Levels
There is a growing awareness of the benefits of allergy immunotherapy among patients and healthcare providers. Allergy immunotherapy has been shown to be more effective than symptomatic treatment options, such as antihistamines or nasal corticosteroids, in reducing allergy symptoms and improving quality of life. It can also help prevent the development of new allergies or asthma, making it a valuable long-term treatment option. Patients are seeking more effective and long-term solutions for managing their allergies, and healthcare providers are recognizing the value of allergy immunotherapy in improving patient outcomes. Therefore, providing additional opportunities for the growth of the allergy immunotherapy market during the forecast period.
Trend for Allergy Immunotherapy Market
Efficiency of subcutaneous immunotherapy is rising its demand
The most popular and efficient type of allergy immunotherapy is subcutaneous immunotherapy (SCIT). It is the only treatment that truly alters the immune system, making it possible to stop the onset of new allergies and asthma attacks. A novel treatment for allergic diseases, subcutaneous immunotherapy alleviates symptoms while altering allergic illness by focusing on the underlying immunological process. In several carefully monitored clinical trials, its effectiveness and safety have been proven. Subcutaneous immunotherapy (SCIT), sometimes referred to as an "allergy shot," is delivered via injection. It is the go-to treatment for allergen desensitisation and offers asthma and allergic rhinitis sufferers symptomatic relief. Sublingual immunotherapy (SLIT) is very effective, which means that throughout the projection period, there will be an increase in demand for the product, driving category growth.
FutureWise Insights: According to FutureWise analysis the market for Allergy Immunotherapy is estimated to be US$ 1599.2 million in 2022, and is expected to grow at a CAGR of 8.8% over the forecast period of 2023-2031. Europe registered highest share in the market in 2022. Additionally, based on allergy type; allergic rhinitis segment holds the highest market share of 71.6% in 2022.
Objectives of Study:
To provide with an exhaustive analysis on the Allergy Immunotherapy Market By Treatment Type, By Allergy Type, By End User and By Region.
To cater comprehensive insights on factors such as drivers, restraints, trends, opportunity, and additionally segmental and regional factors impacting market growth.
To evaluate current market trends and forecast micro-markets and the overall market projections which are represented in the format of data-sets and ppt.
To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
To provide information on competitors which includes landscape mapping, technological advancements, R&D spending, news concerning strategic alliances, and new product launches
Key Takeaways: FutureWise research report will help you understand the growth prospects, key trends, and data points affecting the market's growth. A detailed review of strategies being opted by the players in this market, and a thorough market share registered by the key companies globally as well as on a regional basis.
Delivery model: You can reach us directly at [email protected]. We offer a flexible delivery model wherein you can request changes in the scope/table of content as per your requirements. Customized Mobility Care is free of charge associated with any license purchase of any report.
Related market:
Some of the other related markets that you might be interested in are listed as below:
Radioimmunotherapy Treatment Market
Personalized Immunotherapy Market
Allergy Shots Market
Table of Contents:
Market Introduction
Research Methodology
Executive Summary
Market Variables, Trends, and Scope
Market Overview
Market Analysis Tools
Market Segmentation
Regional Landscape
Market Share Analysis and Competitive Landscape
Company Profiles
Impact of COVID-19
Impact of Russia-Ukraine War
Competitive Intelligence and Competitive Matrix
Major Deals and Strategic Alliances Analysis
Relevant Case Studies and Latest News Updates
Key Takeaway Points from the Analysts at FutureWise Market Research
Frequently Asked Questions:
What are the Allergy Immunotherapy Market’s revenue, sales, and pricing analysis for the top manufacturers globally and based on region?
Which key factors are driving market growth?
What is the historic and forecast CAGR of market?
Which country holds the greater percentage share of market globally?
What current factors are creating opportunities for vendors in this market?
What challenges are being faced by new market entrants in this industry?
How is Russia-Ukraine War impacting the overall growth of this market?
About & Contact Details:
We specialize in high-growth niche “Healthcare” market research, and offer flexibility, agility, as well as tailored solutions & services for our clients. Our research is based on both primary and secondary methods, wherein primary consists of opinions, interviews of key opinion leaders, and high ranked doctors specializing in a particular field of medicine. Our market insights and consulting services enable our clients to stay ahead of their industries for many years.
FutureWise Market Research
Vinay T - Head of Business Development
Email: [email protected]
UK: +44 141 628 9353 | USA: +1 347 709 4931
Website: www.futurewiseresearch.com
